Stock ACR ACRUX LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Acrux Limited

Equities

ACR

AU000000ACR3

Pharmaceuticals

Market Closed - Australian S.E.
Other stock markets
 02:10:05 2024-04-29 am EDT 		5-day change 1st Jan Change
0.061 AUD +1.67% Intraday chart for Acrux Limited +1.67% +38.64%
Apr. 03 Acrux, TruPharma Launch Dapsone 5% Gel in US MT
Feb. 29 Transcript : Acrux Limited, H1 2024 Earnings Call, Feb 29, 2024

Valuation

Fiscal Period: June 2023 2024 2025 2026
Capitalization 1 12.1 17.73 - -
Enterprise Value (EV) 1 12.1 15.03 12.53 2.034
P/E ratio -15.6 x -4.62 x 7.5 x 1.67 x
Yield - - - -
Capitalization / Revenue - 2.73 x 1.44 x 0.88 x
EV / Revenue - 2.31 x 1.02 x 0.1 x
EV / EBITDA - -3.5 x 5.97 x 0.2 x
EV / FCF - -4.42 x 4.64 x 0.19 x
FCF Yield - -22.6% 21.5% 526%
Price to Book - - - -
Nbr of stocks (in thousands) 288,175 290,717 - -
Reference price 2 0.0420 0.0600 0.0600 0.0600
Announcement Date 8/24/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2023 2024 2025 2026
Net sales 1 - 6.5 12.3 20.2
EBITDA 1 - -4.3 2.1 10
EBIT 1 - -3.9 2.4 10.3
Operating Margin - -60% 19.51% 50.99%
Earnings before Tax (EBT) 1 - -3.8 2.4 10.4
Net income 1 -0.764 -3.8 2.4 10.4
Net margin - -58.46% 19.51% 51.49%
EPS 2 -0.002700 -0.0130 0.008000 0.0360
Free Cash Flow 1 - -3.4 2.7 10.7
FCF margin - -52.31% 21.95% 52.97%
FCF Conversion (EBITDA) - - 128.57% 107%
FCF Conversion (Net income) - - 112.5% 102.88%
Dividend per Share - - - -
Announcement Date 8/24/23 - - -
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2023 2024 2025 2026
Net Debt 1 - - - -
Net Cash position 1 - 2.7 5.2 15.7
Leverage (Debt/EBITDA) - - - -
Free Cash Flow 1 - -3.4 2.7 10.7
ROE (net income / shareholders' equity) - - 33% 58.7%
ROA (Net income/ Total Assets) - - 20% 46.2%
Assets 1 - - 12 22.51
Book Value Per Share - - - -
Cash Flow per Share 2 - -0.0100 0.0100 0.0400
Capex - - - -
Capex / Sales - - - -
Announcement Date 8/24/23 - - -
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

1st Jan change Capi.
ACRUX LIMITED Stock Acrux Limited
+38.64% 11.38M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+20.81% 43.34B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.44% 21.96B
SANDOZ GROUP AG Stock Sandoz Group AG
+13.19% 14.09B
CIPLA LIMITED Stock Cipla Limited
+12.97% 13.64B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+39.74% 11.43B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.59% 6.86B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+8.46% 5.22B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ACR Stock
  4. Financials Acrux Limited